Corporate News 22-Jun-24
Cipla's Goa unit completes USFDA inspection
Cipla's manufacturing unit in Goa has received six observations in Form 483 following USFDA inspection from 10 June to 21 June 2024.
Previous News
Cipla allots 35,106 equity shares under ESOP
( Corporate News - 05-Jul-24 11:02 )
Cipla to conduct board meeting
( Corporate News - 05-Jul-24 10:23 )
Orchid Pharma partners with Cipla to launch antibiotic drug - Cefepime-Enmetazobactam in India
( Corporate News - 28-Jun-24 19:23 )
Cipla Ltd eases for fifth straight session
( Hot Pursuit - 25-Jun-24 13:35 )
USFDA classifies inspection of Cipla's Patalganga unit as 'Voluntary Action Indicated'
( Corporate News - 25-Jun-24 12:12 )
Cipla gets VAI classification from USFDA for Patalganga facility
( Hot Pursuit - 25-Jun-24 11:34 )
Cipla slides as Goa facility gets 6 USFDA observations
( Hot Pursuit - 24-Jun-24 09:47 )
Cipla Goa facility gets 6 USFDA observations
( Hot Pursuit - 22-Jun-24 16:22 )
Cipla's Goa unit completes USFDA inspection
( Corporate News - 22-Jun-24 11:47 )
Cipla to invest additional EUR 3 million in Ethris GmbH
( Corporate News - 18-Jun-24 17:19 )
Cipla hits record high as UK arm plans to invest additional 3 mln euro in Ethris
( Hot Pursuit - 18-Jun-24 14:56 )
Other Stories
Board of Delhivery approves alteration in capital clause of MoA
05-Jul-24 19:32
J B Chemicals & Pharmaceuticals appoints director
05-Jul-24 19:30
Infosys announces resignation of senior management personnel
05-Jul-24 19:22
JLR Q1 FY25 retail sales up 9% on YoY basis
05-Jul-24 19:08
Bajaj Auto launches world's first CNG motorcycle 'Freedom'
05-Jul-24 18:59
Agenda for board meeting of Power Grid Corporation of India
05-Jul-24 18:46
Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
05-Jul-24 18:06
Vipul to hold board meeting
05-Jul-24 17:15
Markobenz Ventures to convene board meeting
05-Jul-24 17:15
Dhanashree Electronics to declare Quarterly Result
05-Jul-24 17:15
Back
Top
